New Nano-Drug enters human testing for tough cancers
Disease control
Completed
This was a first-in-human study to find a safe dose of a new experimental cancer drug called SNB-101. The drug, a nanoparticle form of an existing chemotherapy, was given by IV to 21 patients with advanced solid tumors that had stopped responding to standard treatments. The main …
Phase: PHASE1 • Sponsor: SN BioScience • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC